英國Daily Mail 對Paxlovid 引發血栓的研究報道

 

Our gov't just spent another $2 billion on this crap that has gotten no scrutiny and has so many contraindications, plus a ubiquitous rebound effect with symptoms. And again, no long term carcinogenicity studies *****xXCb1XH0n1

— Daniel Horowitz (@RMConservative) December 18, 2022